Apollo Management Holdings’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Apollo Management Holdings’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,774,782	Closed	-$1.53M	–	80
2019 Q4	$1.53M	Buy	1,774,782 +34,750	+2%	+$26.7K	0.01%	49
2019 Q3	$975K	Hold	1,740,032	–	–	0.01%	59
2019 Q2	$905K	Hold	1,740,032	–	–	0.01%	62
2019 Q1	$783K	Hold	1,740,032	–	–	0.01%	69
2018 Q4	$835K	Hold	1,740,032	–	–	0.01%	74
2018 Q3	$922K	Hold	1,740,032	–	–	0.01%	77
2018 Q2	$870K	Hold	1,740,032	–	–	0.01%	78
2018 Q1	$735K	Hold	1,740,032	–	–	0.01%	79
2017 Q4	$661K	Sell	1,740,032 -191,704	-10%	-$72.7K	0.01%	57
2017 Q3	$695K	Hold	1,931,736	–	–	0.01%	59
2017 Q2	$734K	Hold	1,931,736	–	–	0.01%	62
2017 Q1	$869K	Buy	1,931,736 +125,988	+7%	+$55.3K	0.02%	58
2016 Q4	$686K	Buy	+1,805,748	New	+$611K	0.02%	54

Apollo Management Holdings's GCVRZ Position: Q1 2020 in Review

Apollo Management Holdings sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 1,774,782 shares — an estimated $1.53M sold.

Apollo Management Holdings first reported a position in GCVRZ in Q4 2016 and held it in 13 quarters. The position peaked at $1.53M in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

Apollo Management Holdings reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
Apollo Management Holdings sold 1,774,782 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $1.53M.
Apollo Management Holdings first reported a position in Sanofi Contingent Value Rights in Q4 2016 and held it in 13 quarters.
Apollo Management Holdings's Sanofi Contingent Value Rights position peaked at $1.53M in Q4 2019.
2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Apollo Management Holdings's 13F filing for Q1 2020, filed 15 May 2020.